ovarian hyperstimulation syndrome
Conditions
Interventions
Low dose Fangzhi Guoji Prescript particle group:Low dose Fangzhi Guoji Prescript particle
High dose Fangzhi Guoji Prescript particle group:High dose Fangzhi Guoji Prescript particle
Fangzhi Guoji Decoction piece group:Fangzhi Guoji Decoction piece.
Control group:Conventional Western Medicine Treatment
Sponsors
Guangdong Maternal and Child Health Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1) 20.0-39.9 years of age. 2) Patients with IVF/ICSI. estrogen reaches 3000pg/mL during ovulation induction; 3) Agree to participate in clinical research and sign an informed consent form, actively cooperate with researchers, and cooperate with follow-up patients.
Exclusion criteria
Exclusion criteria: 1) Those who are participating in other scientific research projects; 2) Those who fail to take medication as required and cannot determine the efficacy; 3) Individuals who are allergic or uncomfortable with drugs, including severe fever and diarrhea; 4) The patients with embryo transfer were cancelled because of uterine cavity separation, endometrial thickening, uterine fibroids pressing endometrium, positive COVID-19, etc; 5) Patients with atypical endometrial hyperplasia; 6) Patients with diabetes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Waist Circumference;24 h input and output amount;Cancellation rate of fresh embryo transfer; | — |
Secondary
| Measure | Time frame |
|---|---|
| Estrogen;Progesterone ;Number of retrieved oocytes;clinical pregnancy rate; | — |
Countries
China
Contacts
Public ContactNianjun Su
Guangdong Maternal and Child Health Hospital
Outcome results
None listed